

Sirolimus is a powerful immunosuppressive medicine that works by inhibiting the immune system’s response to foreign organs, thereby preventing rejection after transplantation. Maintaining optimal levels of sirolimus is crucial, as insufficient levels may lead to organ rejection, while excessive levels can result in adverse effects and toxicity.
The Sirolimus by LC-MS/MS test is particularly useful for individuals who have undergone an organ transplant. This test helps physicians monitor medication adherence and provides valuable information to adjust dosages accordingly. It is typically performed at regular intervals post-transplant to ensure that individuals achieve and maintain the right levels of sirolimus in the body. The frequency of testing depends on factors such as individual response, type of transplant, time since transplant, age, and overall health. It is also performed when there are dosage changes or if symptoms of side effects, toxicity, or organ rejection are observed.
This test utilizes advanced LC-MS/MS (liquid chromatography-mass spectrometry) technology, allowing for the detection and precise quantification of even very low concentrations of sirolimus in the blood. LC-MS/MS offers higher sensitivity and specificity compared to immunoassays and is considered the gold standard. This enhances the reliability of results and enables timely, accurate dosage adjustments, helping physicians optimize treatment and reduce the risk of complications.
Before the Sirolimus by LC-MS/MS test, a brief medical history is needed, including the timing of transplantation, drug dosage, and the time of the last sirolimus dose. The test measures the ‘trough’ level (the lowest concentration) of sirolimus, typically just before the next scheduled dose, for consistent and accurate results. Therefore, it is advised to provide the blood sample just before the next dose (usually 12 hours post-dose), unless otherwise instructed by a physician. The patient should skip taking the morning dose on the day of testing. It is also advised to avoid grapefruit or grapefruit juice for 24 hours beforehand to ensure an accurate result. The timing of blood collection can significantly impact the measured levels of sirolimus. Meal timing, changes in administration route, or switching between brands of the medicine can also influence blood levels. Following a doctor’s instructions carefully ensures accurate testing and optimal treatment outcomes.
Lab test results may vary across methodologies and laboratories. Therefore, consistent monitoring using the same method and laboratory is recommended. Results may also vary based on age, medical history, or other risk factors. Abnormal results require expert interpretation. Never self-adjust medication at home based solely on test results. Maintaining optimal sirolimus levels improves overall health outcomes and supports long-term success in organ transplantation.
The Sirolimus by LC-MS/MS test measures the levels of sirolimus in the blood. This test helps determine whether the concentration of sirolimus falls within the therapeutic range. Using LC-MS/MS technology, it can accurately detect very small amounts of sirolimus in the blood, providing precise information about the medication level.
Low levels indicate that the dosage may not be sufficient for effective immunosuppression or may reflect missed doses. High levels indicate potential toxicity and increased risk of adverse effects or organ damage. Accurate measurement ensures that doctors can safely adjust the dose, maintaining the right balance between effectiveness and safety, which is particularly critical for transplant patients requiring tight drug level monitoring.
The Sirolimus by LC-MS/MS test is done:
- To monitor sirolimus levels in the body.
- To ensure sirolimus doses are correct and effective post-transplant.
- To adjust sirolimus dosage to achieve and maintain therapeutic levels.
- To check sirolimus levels in cases showing signs of side effects, toxicity, or organ rejection.
- To assess patient response to the medication.
- To determine the frequency of testing based on individual factors.
- To provide insights for doctors to optimize sirolimus therapy.
- Timing of the last Sirolimus dose is important. Please mention the exact time of the last dose taken during the sample collection (e.g., trough level C0 or peak level C2).
- Doctor's prescription, clinical history, and timing of last dose are mandatory.






















